Are you saying the NIH process is corruptible?
I think you are drawing a long bow here.
NIH chose Imm124 as one of three products after reviewing the merits of a vast number, so clearly that was validation.
Not sure the NIH would expose itself in the way you have described above.
Ann: Appendix 4D - Half Yearly Report and Accounts, page-17
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $25.07M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $2.53K | 23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 140596 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 210068 | 2 |
View Market Depth
| Last trade - 15.03pm 22/08/2024 (20 minute delay) ? |
| IMC (ASX) Chart |